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 Obesity has become a major health problem all over the world in endemic 
proportion .Now a day’s obesity affects all the age groups in both men and women. 
Obesity related diseases such as diabetesmellitus; hypertension, heart disease, 
stroke,and arthritisultimately decrease the life span of the individual. 
           Obesity in female population has major impact onpregnancy. The rate of 
obesity in pregnant women is rising and consequently obesity related problems. 
 The pregnancy complication associated with maternal obesity are divided in 
to two groups, 
1. Affectsprimarily the mother. 






 REVIEW OF LITERATURE 
OBESITY 
DEFINITION 
         Obesity is a state of excess adipose tissue mass. Adipose tissue is composed 
of lipid storing adipose cells. Adipose mass increases by enlargement of adipose 
cell as well as by an increase in number of adipocytes. 
METHODS TO GAUGE OBESITY 
         There are number of system to classify obesity .The BODY MASS INDEX is 
also known as QUETLET’S INDEX. BMI is calculated as weight in kilograms 
divided by height in square meters. 
BMI =weight in kg 
Height in m2 
CLASSIFICATION according to BMI. 
According to National Heart, Lung & Blood Institute (1998),  
Underweight BMI= <18.5 Kg/m2 
Normal BMI =18.5 to 24.9 Kg/m2 
Overweight BMI= 25 to 29.9 Kg/m2 
Obesity BMI > 30 Kg/m2. 
  
 
According to Friedman and colleagues (2002), obesity is further categorized into, 
CLASS I   BMI 30 to 34.9 Kg/m2 (high risk). 
CLASS II BMI 35 to 39.9 Kg/m2 (very high risk). 
CLASS III BMI > 40 Kg/m2 (morbid obese). 
         Other approaches to quantify obesity include,  
1.Anthropometry (skin fold thickness). 
2.Densitometry (under water weighing). 
3.CT or MRI & Electrical impedance. 
WAIST-TO-HIP RATIO. 
 The most important complication of obesity are insulin resistance, diabetes, 
hypertension, hyperlipidemia, and hyperandrogenism .Obesity in women is linked 
more strongly to intraabdominal and or upper part of body, than to overall obesity. 
Specifically, intra abdominal and abdominal subcutaneous fat i.e., APPLE SHAPE 
has more significance than fat around hip and buttocks i.e., PEAR SHAPE. 
  This can be easily measured by waist-to-hip ratio, with a ratio > 0.9 in 
women and >1.0 in menbeing abnormal. And also waist circumference >88cm, is 






In 2005, approximately 1.6 billion adults were overweight and at least 400 
million adults were obese and 22% of adults were obese all over the world. By 
2000, about 34% of adults in US were overweight, and 27% were obese. This is a 
75% increase when compared with 1980 statics by Pies and colleagues (2003). 
Mokdad and associates (2003) reported that 2.8% of women and 1.7% of men are 
extremely obese class III with the BMI of 40 kg/m2. 
 
PREVALANCE IN INDIA 
The NFHS 2006, 10% of Indian population were either overweight or obese. 
About 30 million Indians are obese and around 20% of school isoverweight. 
According to NFHS percentage of married women in age 15 to 49, are overweight 
or obese increasing from 11% by NFHS 2 to 15% by NFHS 3. Obesity is 3 times 
more prevalent in urban areas than rural areas. More than one third of obesity is in 
higher income group. 
 
PHYSIOLOGY REGULATION OF ENERGY BALANCES. 
 Body weight is regulated by both endocrine and neural components that 
influence the effector arms of energy intake and expenditure. 
In weight loss, appetite increases and energy expenditure falls. With over feeding, 
appetite falls and energy expenditure increases. In obesity, the latter part fails. 
When food is abundant and physical activity is limited the outcome is obesity. 
LEPTIN 
• Adipocyte derived hormone. 
• Major regulator of adaptive responses in weight loss and weight gain. 
• Acts mainly on brain predominantly in hypothalamus. 
• To influence appetite,energy expenditure and neuroendocrine function. 
• When leptin level increases, food intake decreases & energy expenditure 
increases and, when leptin level decreases, food intake increases & energy 
expenditure decrease. 
HORMONES 
Leptin, insulin, cortisol and gut peptides. 
 
ENERGY EXPENDITURE 
1. Resting or basal metabolic rate (70%). 
2. Energy cost of metabolizing & storing food. 
3. Thermic effect of exercise (5-10%). 
4. Adaptive thermogenesis. 
PATHOPHYSIOLOGY 
 There is a sensing system in adipose tissue that reflects fat stores, in the 
hypothalamus by a receptor “ADIPOSTAT”.When fat store is depleted, 
adipostat signal is low and the hypothalamus stimulateshunger & decreases 
energy expenditure to conserve energy. Conversely, when fat stores are 
abundant, the signal is increased and the hypothalamus responds by 
decreasing hunger and increasing energy expenditure. 
 Obese people have increased leptin levels not due to mutation in gene but 
due to leptin resistance. 
ETIOLOGY OF OBESITY  
 A chronic excess of nutrient intake relative to the level of energy 
expenditure  
 
ROLE OF GENES VERSUS ENVIRONMENT 
• Obesity commonly runs in families. The inheritance is usually not 
Mendalian. 
• Environment also plays a key role; famine prevents obesity even in most 
obesity prone individual. 
• Cultural factorsare also important. 
• High fat diet & simple carbohydrate promote obesity. 
 
OTHER SYNDROMES ASSOCIATED WITH OBESITY 




CONSEQUENCES OF OBESITY IN GENERAL 
1. Metabolic syndrome.  
Onset of insulin resistance causes type 2 diabetes mellitus. Type 2 diabetes, 
dyslipidemia and hypertension clustered with other subclinical 
abnormalities, are referred to as the “metabolic syndrome”65. 
Hyperinsulinemia and insulin resistance are pervasive features of obesity, 
increases weight gain and decreases weight loss. Onset of Diabetes requires 
an interaction between Obesity-induced insulin resistance and impaired 
insulin secretion 
2. Cardiovascular disease 
                          Heart disease due to obesity “ADIPOSITAS CORDIS”- is caused 
by hypertension, hypervolemia, and dyslipidemia. Higher rates of left 
ventricular dysfunction, heart failure, myocardial infarction, and stroke have 
been noted14. Excessive weight is associated with increased early mortality 
rates. 
 LONG TERM COMPLICATION OF OBESITY (WILLIAMS 23RD EDITION) 
                 DISORDER                POSSIBLE CAUSES 
Type 2 diabetes mellitus Insulin resistance 
Hypertension Increased blood volume and cardiac 
output      
Coronary heart disease  Hypertension, Dyslipidemia, Type 2 
diabetesmellitus 
Obesity cardiomyopathy Eccentric left ventricular hypertrophy 
Sleep apnea/ pulmonary dysfunction Pharyngeal fat deposition  
Ischemic stroke Atherosclerosis, decreased cerebral 
Blood flow 
Gall bladder disease  Hyperlipidemia 
Liver disease- 
nonalcoholicsteatohepatitis (NASH) 
Increased visceral adiposity; elevated 
serum free fatty acids; hyperinsulinemia 
Osteoarthritis Stress on weight bearing joints 
Subfertility Hyperinsulinemia 
Cancer- endometrium, colon and breast Hyperestrogenemia 
Carpal tunnel syndrome  
Deep venous thrombosis  






Obesity occurs in more than 50% of patients with PCOS. The body fat is 
usually deposited centrally (android obesity), and a higher waist-to-hip ratio is 
associated with insulin resistance indicating an increased risk of diabetes mellitus 
and cardio vascular disease. Insulin resistance resulting in hyperinsulinemia is 
commonly exhibited in PCOS. About one –third of obese PCOS have impaired 
glucose tolerance (IGT), and 7.5% to 10% have type 2 diabetes mellitus. Abnormal 
lipoproteins are common in PCOS. 
SUBFERTILITY 
               Obesity is associated with subfertility due to increased insulin resistance. 




              Obesity is associated with increased risk of first-trimester and recurrent 
miscarriage. Bellver and associates (2009) found that implantation; pregnancy and 
live-birth rates were progressively and significantly reduced with each unit of 
maternal BMI. Obese pregnant women have increased use of health services37.  
Morbid obesity is harmful to the pregnant women and her fetus15. 
 
PREECLAMPSIA 
 Obesity is a consistent risk factor for preeclampsia. Its risk is doubled with 
each 5 to 7 kg/m2 increase in prepregnancy BMI45. Obesity is associated with low 
grade inflammation and endothelial activation.  Endothelial activation also plays an 
integral role in preeclampsia62. 
 Obese patients have significantly elevated serum levels of interleukin-6 and 
C- reactive protein as well as evidence of impaired endothelial function49. Obese 
gravid women have significantly higher levels of triglycerides, very-low-density 
lipoprotein, cholesterol, insulin and leptin compared with normal- weight pregnant 
woman. 
Cedergren, (2004); Jensen (2003); Sebire, (2001); Weiss, (2004) and all their 
colleagues found that obesity is a consistent risk factor for preeclampsia. 
Cunningham and associates, (1986) found obesity and hypertension are common 
cofactors in causing peripartum heart failure. 
GESTATIONAL DIABETES 
 Obesity is associated with marked increase in gestational hypertension and 
diabetes. Pregestational diabetes increases the rate of birth defects, and gestational 
diabetes is complicated by excessive number of large-for-gestational age and 
macrosomic fetuses60. 
 Obesity is a risk factor for carbohydrate intolerance both in pregnant and 
nonpregnant women. The fasting and post-prandial plasma insulin has been shown 
to be higher in obese pregnant women when compared to non obese. In overweight 
women with a BMI with 25-30, the incidence of gestational diabetes is 1.8-6.5 
times and in those with a BMI >30, 1.4-20 times greater than the controls. 
Weiss and associates (2004) – FASTER (First and second Trimester 
Evaluation of Risk trial) showed marked increases in gestational hypertension and 
diabetes in class 1 and class 2 obesity. Cedergren, (2004); Jensen (2003); Sebire, 
(2001) and all their colleagues found that obesity is a consistent risk factor for 
preeclampsia. 
RESPIRATORY COMPLICATION 
 Obesity decreases chest wall compliance and increases airway resistance 
and work of breathing. A decrease in forced vital capacity and forced expiratory 
volume at one second in noted in obese individuals during respiratory studies 
compared to normal weight women42. Recent sleep a study shows that increased 
rates of snoring and sleep related apnea and hypoapnea in obese pregnant woman58. 
INFECTION 
 There are some suggestions for increased urinary tract infection in obese 
pregnant women53. 
MALPRESENTATION 
 Malpresentation like breech is more common in obese women and is not 
only difficult to detect but also difficult to correct by external version. 
Ultrasonography may be necessary to confirm the presentation, exclude multiple 
pregnancy and monitor the fetal growth rate. Kinoshita and Itoh (2006) found using 




 Labour is no better favored by obesity. The need for induction is higher 
because of hypertension, pre-eclampsia, diabetes or postdatism, and labour is often 
tiresomely inert and incoordinate. Minor degrees of disproportion may only declare 
themselves by unsatisfactory labour.  
The need for operative delivery both by forceps and Caesarean section is 
about doubled. Primary Caesarean section is most commonly done for CPD. Haeri 
and co-workers (2009) also found increased rates of cesarean delivery and 
gestation diabetes in obese adolescents. Lynch and associates, 2008, Poobalan and 
colleagues, 2009 reported increased rates of emergency cesarean delivery in obese 
women.  
Asbee and associates (2009) randomized 100 women to receive either 
additional intensive dietary or lifestyle counseling during gestation or to receive 
routine prenatal care. Women assigned to routine prenatal care had significantly 





 Obese women present anesthesia challenges that include difficult epidural 
and spinal analgesia placement and complications from failed or difficult 
incubations29. Regional anesthesia is to be preferred to general anesthesia.  
POSTPARTUM COMPLICATIONS 
WOUND INFECTION 
In obesity post operative wound infection are common6, 53.The Pfannenstiel 
incision is advantageous in obese women from the point of recovery, although it 
may not be a comfortable incision for delivering a large baby. Wall and colleagues 
(2003) reported a fourfold increase in wound complication rate when a vertical 
abdominal incision was compared with a transverse incision. 
Subcutaneous closure in wound thickness > 2 cm resulted in6% decrease in 
wound disruption13. There is a 2 to 3 fold increased risk of infection in overweight 




 Postpartum hemorrhage is also more common because of the delivery of 
macrosomic babies. Obese women had a 70% increase in PPH; though it is difficult 
to quantify blood loss there is a definite need for blood transfusion6. Postoperative 
complications are more common, veins are less accessible for transfusion and the 
duration of hospital stay is longer.  
 
LACTATION 
Li and colleagues (2003) found that obese women are less likely to breast 
feed than normal weight women. They also have greater weight retention in one 
year after delivery (Catalano 2007). Excess weight gain during pregnancy is 
difficult to shed in postpartum period, and it is an additional contributing factor to 
obesity in parous women. 
 
THROMBOEMBOLISM 
 Pregnancy results in venous stasis and activation of clotting system, putting 
pregnant women at risk of thromboembolic disease. Obesity is qualitatively 
considered to place a pregnant woman in a “moderate risk” group in terms of 
thromboembolic events, especially if she undergoes cesarean section19. Deep vein 
thrombosis and pulmonary embolus causes morbidity &mortality and perioperative 
prophylaxis is indicated. 
 
POSTPARTUM DEPRESSION 
 Lacoursiere and Varner (2009) found that postpartum depression was 
significantly increased in obese women and also relation to the degree of obesity 
CLASS I (22.6%), CLASS II (32.4%) and CLASS III (40%). 
CONTRACEPTION 
 Women with weight more than 70.5 kg on oral contraceptives havemore 
failure rate and pregnancy increased by 1.6 fold by Holt and colleagues (2009). 
PERINATAL MORTALITY 
 An increased incidence of late-pregnancy stillbirths has been associated 
with obesity. A significant 1.6-fold increase in the stillbirth rate 16was noted in 
women with a  BMI of 25 to 29.9 kg/m2 and the rate increased 2.6-fold for women 
with a BMI >30kg/m2. Compared with normal weight women, the fetal death rate 
among obese women increased with gestational age. The hazard ratio was 2.1 at 28 
to 36 weeks, 3.5 at 37 to 39 weeks, and 4.6 at 40 or more weeks44. The stillbirth 
rate was 240% greater in obese compared with normal-weight women. 
CONGENITAL ANOMALIES 
 In 2000, Women with a BMI > 30kg/m2 had a twofold increase incidence of 
neural tube defects compared with that of control women56. In 2008, it was 1.2-, 
1.7-, and 3.1-fold increased risk in overweight, obese, and severely obese women 
compared to controls of normal weight50. A two-to threefold increased incidence in 
omphalocele, heart defects and multiple anomalies was also noted in obese women. 
  
MACROSOMIA 
 Pregestational diabetes is complicated by excessive number of large –for-
gestational age and macrosomic fetuses. Even without diabetes, the prevalence of 
macrosomic newborns is increased in obese women6, 10, and 37. The prepregnancy 
BMI exhibits the strongest influence on the prevalence of these neonates9, 22, 54. 
CHILDHOOD OBESITY 
 Maternal obesity is linked with increased childhood obesity in a linear 
association4. Breast feeding decreases the risk of childhood obesity. Catalano and 
colleagues (2005) studied offspring at a median age of 7 and found a direct 
association with maternal prepregnancy obesity and childhood obesity. 
 
MANAGEMENT 
• A program of weight reduction is not possible during pregnancy. If such 
regimen is chosen, it is mandatory that the quality of diet be monitored closely 
and ketosis should be avoided. Obese and overweight women should limit 
weight gain to 15 pounds. 
• Advise screening of all obese pregnant women for diabetes at first visit to 
hospital. If negative then at 26 weeks of gestation to rule out gestational 
diabetes. This is not indicated where universal screening for gestational 
diabetes mellitus is practiced. 
• Closely monitor for preeclampsia, with appropriately sized blood pressure 
cuff. 
• Standard screening tests for fetal anomalies at 18 to 22 weeks. 
• Accurate assessment of fetal growth usually requires serial sonography. 
• Antepartum and intrapartum fetal heart rate monitoring is difficult and even 
impossible. 
• Strongly consider caesarean delivery if the estimated fetal weight is >4.5 Kg 
in an obese woman with diabetes, and when estimated fetal weight is 5 Kg for 
obese woman without diabetes. 
• Obese women undergoing caesarean section should receive prophylactic 
antibiotics and thromboembolic prophylaxis. 
• Graduated compression stockings, hydration, and early mobilization are 
recommended in obese women after caesarean delivery2. 
• Encourage the mother to breastfeed; it not only benefits the baby but also 
enhances postpartum weight loss and decrease the likelihood of developing 
childhood obesity. 
• Reinforce the need for continued healthy patterns of eating and physical 
activity so that optimal weight can be attained in the postpartum period. 
• Women who had gestational diabetes should also undergo a 75g oral glucose 
tolerance test and to measure BP at 6 weeks postpartum. 
 The 1990 Institute of Medicine recommended total gestational weight gain 
ranges for pregnant women by the prepregnancy BMI. 
  
 CATEGORY BODY MASS INDEX KILOGRAMS POUNDS 
Underweight  < 18.5 Kg/m2 12.5 to 18 28 to 40 
Normal 18.5 to 24.9 Kg/m2 11.5 to 16  25 to 35  
Overweight 25 to 29.9 Kg/m2 7 to 11.5 15 to 25 
Obese >30 Kg/m2 5 to 9.1 11 to 20 
 
Cogswell and associates (2006) reviewed gestational weight gain across 
BMI categories from 1990 through 2003. They reported that one third of pregnant 
women gained weight within the IOM recommendations. 
PREGNANCY FOLLOWING BARIATRIC SURGERY 
  There is an improved fertility and reduced risks of obstetrical complication 
following bariatric surgery compared with morbidly obese controls25.Many women 
become pregnant following weight reduction surgery1. The three procedures 
commonly performed currently are,  
1. Verticalgastroplasty. 
2.Gastric banding and, 
3. Roux-en-Y gastricbypass. 
  
 In a comparative study of pregnancy outcome in women who had 
undergone bypass  with previous pregnancy outcome of same women, had a 
dramatic reduction in hypertension- 40 versus 0%, diabetes- 24  versus 0% and 
baby weight >4kg-30 versus 5%61. 
  
 Moore and colleagues (2004) and Wax and associates did not report any 
serious complications with, Roux-en-Y gastricbypasssurgery but there were cases 








AIM AND OBJECTIVES 
 
 
The aim of this study is to evaluate the influence of obesity on 











 MATERIALS AND METHODS 
 
STUDY DESIGN:  Prospective cohort study. 
STUDY PLACE:  Institute of Social Obstetrics, ISO-KGH, Triplicane, Chennai.  
STUDY PERIOD: January 2012 to December 2012 
The study was approved by the Institutional Review Board (Ethical Committee). 
After getting consent, detailed history was elicited and the mothers were examined 
in detail. The selected women were divided into 2 groups based on their BMI.                
GROUP A (Control Group):300 women with normal BMI 18.5 to 24.99 Kg/m2.. 
GROUP B (Study Group):300 women with obesity BMI > 30 Kg/m2. 
                Class I: 30-34.99kg/m2 
                 Class II: 35-39.99kg/m2 






 Pregnant women with prepregnancy BMI >30kg/m2. 
2. Pregnant woman with prepregnancy BMI between 18.5kg/m2 and 
24.99kg/m2. 
3. Similar socioeconomic status. 
4. Matched dietary habits. 
EXCLUSION CRITERIA 
1. Women not booked at KGH and whoseprepregnancy BMI not known. 
2. Women whose BMI < 18.5kg/m2. 
3. Women with BMI between 25kg/m2 and 29.9 kg/m2. 
4. Women who are obese already with medical complication like diabetes, 
hypertension and hypothyroidism. 
5. Women who could not be followed until delivery. 
FOLLOWING DATA WERE ANALYSED 
I. Growth of uterus 1. Symphysio fundal height 
 2. Abdominal circumference 
II. Increase or decrease in maternal weight 
III. Complication during antenatal period 
1. Gestational Diabetes 
2. Anemia 
3. Preeclampsia 
IV. Onset of labour 
 1. Preterm 
  2. Term 
 3. Post Dated 
  4. Antepartum hemorrhage 
V.  Induction or acceleration of labour 
VI. Type of delivery 
1. Labour natural 
2. Instrumental vaginal delivery 
3. Cesarean section 
VII. Complication during labour 
1. Delay inprogress of labour 
2. In coordinate uterine contraction 
3. Prolonged second stage of labour 
VIII. Third stage complication 
1. Postpartum hemorrhage 
2. Retained  Placenta 
IX. Fetal Complications 
1. Macrosomia 
2.  NICU admission 
3. Stillbirth 






























< 20 YEARS 48 16% 15 5% 
21 to 25 YEARS 164 54.7% 114 38% 
26 to 30 YEARS 82 27.3% 125 41.7% 
>30 YEARS 6 2% 46 15.3% 
 
 
TABLE:-1 shows the age distribution in control and obese groups. 54.7% of  
 
control group were in 21 to 25 years and 41.8% of obese group were in 26  
 












CHART:-1shows that obese was found to be more in women during their active 






















AGE  DISTRIBUTION 
CHART:-1 
 



























NO % WITHIN GROUP NO 
% WITHIN 
GROUP 
PRIMI 161 53.7% 117 39% 
G2 AND 
G3 127 42.3% 158 52.7% 
G4 AND 




TABLE:-2shows the distribution of cases in gravida in control and obesegroup. 
The percentage of primi in control group is 53.7% and obese group is39% but multi 





















CHART:-2 Shows number of primi were more in control group about 161, 
 
























































OBESE WOMEN IN OBESITY CLASSIFICATION 
 
 
     CLASSIFICATION OF         
OBESE WOMEN 
 
       NO OF OBESE 
 
% WITHIN GROUP 
 




















TABLE:-3shows the percentage of obese cases in obesity classification. In  
 
























CHART:-3shows the percentage of obese women distributed in obesity 
 













% OF OBESE WOMEN IN OBESITY 
CLASSIFICATION
-3 


























MEAN BMI AND WEIGHT GAIN
 
 




         
 
MEAN  BMI 
 
              
 
MEAN WEIGHT GAIN   
 
            
 
TABLE:-4shows the mean BMI of control and obese group. The average BMI in 
control group is 22.36 with weight gain of 11.4 kg and in obese group the mean 
BMI is 33.09 with the weight gain of 7.5 Kg.
     
CHART:-4 shows the average BMI in control group is 22.36 with weight 
gainof 11.4 kg and in obese group the mean BMI is 33.09 with the weight 
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TABLE:-5shows the fetal presentation in labour in control and obese cases.  
 


























































   TABLE:-6 
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            OBESE 
 
 










         0 
 
      0% 
 
    27 
 




         9 
 
        3% 
 
    15 
 
        5% 
 
TABLE:-6shows the incidence of gestational diabetes in control and obese  
 
group.  In obese group GDM on in insulin is 9% and on mealplan is 5% with  
 


















     
    
 
 
CHART:-6shows the number of cases in control and obese group.


















































PREGNANCY INDUCED HYPERTENSION 
 
 
  PIH 
 
              CONTROL 
 
                 OBESE 
 








   MILD  
 
       26 
 
      8.7% 
 
      181 
 
    60.3% 
 
    SEVERE 
 
        0 
 
        0% 
 
         42 
 
      14% 
 
 
TABLE:-7shows the incidence of PIH in control and obese group. In control group 
about 8.7% were mild PIH and in obese 60.3% were mild PIH and 14% were 




















CHART:-7 shows that in control group about 26 cases were mild PIH and in obese 


























































       
 
NO OF CASES 
 
             
 
% WITHIN GROUP 
 
              
 
TABLE:- 8 shows the incidence of abruption placenta in control and obese 
group. 3% of women in obese group had 
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0% 
 
             3% 














        ANEMIA 
 
      
 
     NO OF CASES 
 
   % WITHIN GROUP 
 
TABLE:-9 shows  about  2.3%  anemic cases in control group and  6.3% 
 


































































         CONTROL 
 
            OBESE 
 









           TERM 
 
 
      296 
 
 
    98.7% 
 
 
    267 
 
 
     89% 
 
 
         PRETERM 
 
 
        4 
 
 
    1.3% 
 
 
      33 
 
 
      11% 
 
TABLE:-10shows the incidence of gestational age at labour in control andobese 
group. About 1.3% was preterm in control group and 11% were preterm in obese 









CHART:-10 shows about 4 cases in control group were preterm and about 
 






































































INDUCTION OF LABOUR 
 
 
INDUCTION OF LABOUR 
 
      CONTROL 
 
          OBESE 
 










     24 
 
       8% 
 
   27 
 
       9% 
 
OXYTOCIN  INDUCTION 
 
      0 
 
        0 
 
    27 
 





   128 
 




    57 
 
      19% 
 
TABLE:-12 shows the incidence of induction of  labour in control andobese  
group. There is an increased number of induction in obese group compared to 



















CHART:-11 shows in obese group, about cases in 27 cases 
 
with PGE2 gel and 27 cases with oxytocin and in control more number of 
 
























































TYPE OF DELIVERY 
 
            CONTROL 
 
             OBESE 
 










   240 
 
     80% 
 
    63 
 




    44 
 
    14.7% 
 
   102 
 





     14 
 
     4.7% 
 
    108 
 
    36% 
 
ELECTIVE LSCS  
 
      0 
 
       0% 
 
      6 
 
      2% 
 
ELECTIVE REPEAT LSCS 
 
      0 
 
       0% 
 
     12 
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      0.7% 
 
      9 
 
       3% 
 
TABLE:-12 shows the incidence of type of delivery in control and obese  
 
women in control group about 80% of  cases had labour natural and in obese  
 








CHART:- 12 shows in control group 240 cases had labour natural and 210 
 































































 Chart:- 13 shows the incidence of delivery in control group, 80% had labour
 





































CHART:-14 shows the incidence of delivery in obese group, 76% had caesarean 
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TABLE:-13 shows the incidence of deliveries in primi and multigravida of  
obese group, 80.9% of obese primi had caesarean delivery compared to 62%  















Chart:-15 shows the percentage of deliveries in primi and multigravida of 
obesegroup. There is an increased incidence of emergency caesarean delivery in 





































Chart:-16shows the percentage of delivery in obese 






































Chart:-17shows the incidence of delivery in obese group multigravida. 
 




































INDICATION FOR LSCS 
 
























































































TABLE :-15 shows the incidence of indication for caesarean delivery in  
 












































DELAY IN PROGRESS 
 
NUMBER OF CASES 
 
% WITHIN GROUP 
 
TABLE:-15 shows the incidence of delay in progress in control and obese 
 
group. 8.7% cases in obese group had delay in progress.
 
 
















































TABLE:-16 shows 2% of obese women had PPH and 1% retained placenta 
 
with p value <0.001 
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   BABY WEIGHT 
 
     
 
    MEAN WEIGHT 
 
       
 
TABLE:-17 shows the mean baby weight of control and obese group were 
 
2.82 kg and 3.47 kg respectively.
CHART:-21  shows the mean baby weight of control and obese group were 
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     STILLBIRTH 
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TABLE:- 18 shows the incidence of still birth in obese group.2% of obese 
 
group had stillbirth. 
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TABLE:-19 shows the incidence of admission in control and obese group, 
 
about 10% and 34.6% with p value <0.001
   
 
CHART:-23 shows NICU admission of 30 cases in control group and 104 
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      56.6% 
 
         31 
 
     29.8%   
 
TABLE:-20 shows the indication for NICU admission in control and obese  
 
group. 56.6% of control cases were admitted for meconium aspiration and  
 













CHART:-24showsthe indication for NICU admission in both control and 
obese group. 17 cases in control group were admitted for meconium aspiration and 















































            The age group distribution in this study shows that percentage of normal 
weight women are more in 21-25 years of age (54.7%) whereas percentage of 
obese women are more in the 26-30 years of age (41.7%). In women above 30 yrs 
of age, there is increased number of obese women (15.3%), when compared to only 
2 % of normal weight women. The incidence of obesity increases with increase in 
age. The mean age for the normal weight women is 23.75 and for the obese women 
are 26.53. 
 The incidence of obesity increases with parity. In the normal weight group, 
53.7% were primi and 42.3 % were multiparous.  Whereas in the obese grouponly 
39% women were primipara and 52.7% were multiparous. In grand multiparous 
women, 4% were normal weight and 6.2% were obese and p value is < 0.001. 
Multiparous are more prone for obesity than primipara. 
 According to the obesity classification about 84.3% women falls in class I, 
10.7% in class II, and 5% in class III. This shows there are increased number of 
cases in class I obesity when compared to class II and class III. The mean BMI of 
normal weight women is 22.36 and that obese woman is 33.09. 
 The mean weight gain in the normal weight women is 11.41 kg and in the 
obese women is 7.5kg. The obese women gain less weight in pregnancy compared 
to the normal weight women.            
 In the obese women, 97% of the fetus wascephalic, 2% were breech and 1% 
was transverse lie, compared to the normal weight women where 98% were 
cephalic, 1.6% breech and 0.3% transverse lie. There is no significance. 
 The present study revealed a higher prevalence of GDM in obese women. 
Whereas 9% and 5% of obese women were on insulin and meal plan for the 
management of GDM, only 3% of women with normal weight were on meal plan 
with the p value is < 0.001.There were no women on Insulin in the normal weight 
group. This is in concurrence with the study of Weiss and associates (FASTER 
Trial, 2004) which showed a marked increase in gestational hypertension and 
diabetes of class I (10.2% & 12.3%) and class II (6.3% & 9.5%). In general 1-3% 
of all pregnancies are diagnosed as gestational diabetes, while obese women have 
approximately 17% according to Gabee et al (1986). 
 Pregnancy induced hypertension in antenatal period is higher in obese 
women (mild PIH of 60.3% and severe PIH of 14%), when compared to normal 
weight women with mild PIH of 8.7% with the p value < 0.001. O’Brien and 
associates (2003) reported that preeclampsia risk doubles with each 5 -7 kg/m2 
increase in prepregnancy BMI. Similarly Seibre et al (2001) reported a 2 - 4 fold 
increase in preeclampsia in obese women. Kumari et al (2001) reported that 
preeclampsia in obese women was           14-25%.   
 The percentage of anemia in obese women was 6.3% compared to only 2.3 
% in normal weight women. Abruptio placenta is seen in 3% of obese women. 
 Most of the women, about 89%, with obesity proceeded to term gestation 
and preterm labor was noted in only 11%. In normal weight women 98.7% were 
term gestation and 1.3% is preterm with the p value <0.001. This is in concurrence 
with the study of Cnattingius et al who reported an increased risk of delivery before 
32 weeks in nulliparous obese women versus lean women (odds ratio 1.6 with a 
rate of 1.7% as well as a higher rate of 5-6 per 1000). Similar findings for preterm 
delivery were reported by Baeten et al.  
 The incidence of induction of labor was more in obese women due to 
indications like preeclampsia, gestational diabetes and fear of stillbirth in advanced 
gestation. The labor was induced with PGE2 gel in 9% and with oxytocin in 9%. In 
those women with normal weight, PGE2 gel induction was 8% but oxytocin 
induction was 42.7% with the p value <0.001 .This also correlates well with the 
study of Sebire et al (2001) who reported an increased rates of  labor  induction in 
obese women. But in another study Bianco et al (1998) reported the rate of 
oxytocin augmentation was similar in both the groups.  
  
 In the type of delivery, labor natural was about 80% in normal weight 
women compared to only 21% in obese women. The emergency caesarean delivery 
was 14.7% in normal weight women and 34% in obese women. The emergency 
repeat caesarean delivery rates were 36% in obese women and 4.7% in normal 
women. In the obese group, the labor natural in primigravida was 11.6% and 27% 
in the multigravida, emergency caesarean delivery in primigravida was 79% and 
63.1% in multigravida. Elective caesarean section in obese women for primi was 
4.6% and repeat section was 7% and Instrumental delivery for primigravida was 
4.6% and for multigravida was 1.75%. Obese women have increased emergency 
caesarean delivery, compared to the normal weight women because of the 
macrosomia . This study shows there is a significant rise of caesarean delivery with 
obese women with the p <0.001. Our study is in accordance with the study of 
HughM.Ehrenberg (2004) who reported a higher chance of cesarean delivery in 
obese women (13.8% versus 7.7%, P< 0.0001). Lynch and associates 
(2008),Poobalan and colleagues (2009) also found that obese women have 
increased rate of cesarean delivery. Sebire (2001) and Baeten et al (2001) and 
Bianco et al (1n 1998) reported increased cesarean rate in obese women of more 
than 30%. 
 The most common indication for cesarean delivery was previous cesarean 
delivery in both in normal and obese women, whose percentages are 24% and 52.6 
respectively. In the indication for primary section of obese women cephalo pelvic 
disproportion stands first and it is 17.5%. In the normal weight women fetal 
distress was the most common indication with an incidence of 32.7%. Failed 
induction is one of the reasons for caesarean delivery in obese women and it is 
about 5.2%. Severe preeclampsia is an indication in 3.4% of normal weight women 
compared to 10.5% of obese women. Whereas 2.6% and 1.3% of cesarean 
deliveries in obese women were due to malpresentation like breech and transverse 
lie respectively, 8.6% and 1.7% of the same was noted in normal weight women. 
The labour was prolonged in 8.7% of obese women. 
 Third stage complications were more in the obese women, with PPH (2%), 
and Retained placenta(1%). Sebire et al (2001) also reported a higher incidence of 
PPH. 
 The mean birth weight in normal weight women was 2.82 kg and in obese 
women it was 3.47 kg. Hugh M.Ehrenberg et al (2004) opined that obese women 
were at a higher risk of delivering large for gestational age babies (LGA) compared 
to women with normal weight(16.8% vs. 10.5%; P<0.0001). 
Sebire et al (2001), Baeten et al (2001) and Ray et al (2001) also reported that 
maternal obesity is associated with an 18% incidence of LGA neonates, which is a 
two fold increase over rates found in non obese controls. 
               The NICU admission were increased in obese women about 34.66 % 
compared to 10% in normal weight women with the p value <0.001%. The 
indication for NICU admission waspreterm, baby of GDM mother and meconium 
aspiration syndrome. In control group 4 babies are preterm (13.3%), 9 babies are 
baby of GDM mother (30%) and 17 babies are meconium aspiration syndrome 
(56.6%).  In obese group preterm are 33 babies (31.7%), baby of GDM mother are 
40 babies (40%) and with meconium aspiration, 31 babies (29.8%). In the obese 
group increased number of GDM mothers, hence more babies are admitted. Higher 
still birth rates were noticed in the obese women (about 2%). This may due to the 
associated factors severe preeclampsia, followed by abruption or gestational 
diabetes with obesity. 
 Maternal obesity more often leads to intrauterine fetal death. A recent 
Swedish study found a three –fold higher risk in women with morbid obesity. Our 
study has similar results with that of Stephansson et al. The risk of intrauterine fetal 





 This study was conducted at The Institute of Social Obstetrics and 
Govt.Kasturba Gandhi Hospital, Chennai during the period  January 2012 to 
December 2012.  
 300 normal weight women with the prepregnant BMI of 18.5 to 24.9kg/m2 
taken as control and 300 obese women with the prepregnant BMI > 30 kg/m2 as 
study group. 
The study revealed the following findings: 
1. The study group had an increased incidence of obesity in the active 
reproductive age group compared to the control group.  
2. The mean age of control group is 23.75 and for the obese group are 26.53. 
3. In age group above 30 years, obese women are 15.3% and normal weight 
women are 2%. 
4. Whereas the control group had more primigravida (53.7%), there were more 
multigravida women (58.9%) in the study group. 
5. The average BMI of control group is 22.36 and for obese BMI are 33.09. 
6. 84.3% of obese women were in the Class I obesity with 10.7 and 5% in 
Class II and III obesity respectively. 
7. The mean weight gain in control group is 11.41kg and in obese group it was 
7.527 kg. 
8. The presentation in obese group is same with the control group. 
9. More women in the study group had GDM (14%) compared to control group 
(3%). Whereas 9% of the GDM in obese group were on meal plan, 5% had 
to take Insulin for the control of GDM. 
10.  The incidence of PIH in control group is 8.7% (mild PIH) and in obese 
group is 74.3% of which 60.3 %( mild PIH) and 14 %(severe PIH). 
11. Prevalence of anemia in control group was 2.3% compared to 6.3% in the 
obese group  
12. Placental abruption was seen in about 3% of obese women. 
13. There were 98.7% term deliveries in the control group compared to study 
group with 89% term deliveries. Preterm deliveries were more common in 
the obese group (11%). 
14. Induction of laborin control group with gel was 8% and in obese group with 
gel 9% and oxytocin 9%. 
15. Acceleration of labour with oxytocin in control group was 42.7% and 19% in 
obese group. 
16. 80% of mothers in the control group had normal labor compared to 21% in 
the obese group. 
17. Emergency caesarean delivery in control group is 14.7% and in obese group 
is 34%. Emergency repeat caesarean delivery in control group is 4.7% and 
36% in obese group. 
18. Elective caesarean delivery in obese women was performed for 4.6% as 
primary section and 7% as repeat section. 
19. Instrumental delivery with forceps was used in 0.7% of women in the control 
group and in 3% of women in obese group. 
20. The indication for caesarean delivery was previous cesarean delivery in 
24.1% of women in control group and 52.6% in obese group. 
21. The indication primary caesarean delivery is fetal distress 32.7% in control 
group and cephalopelvic disproportion in obese group is 17.5%. 5.2% of 
caesarean delivery in obese group was due to failed induction  
22. Whereas 8.7% of women had CS due to delay in progression of labor, no 
such indication was noted in the non obese women.  
23. Third stage complications noted in obese group were PPH (2%) and retained 
placenta (1%). 
24. The mean baby birth weight in control group is 2.82 kg and in obese group is 
3.47 kg. 
25. The NICU admission in control group is 10% and in obese group is 34.6%. 
26. The indication for NICU admission was preterm, baby of diabetic mother 
and meconium aspiration syndrome. . In control group 4 babies are preterm 
(13.3%), 9 babies are baby of GDM mother (30%) and 17 babies are 
meconium aspiration syndrome (56.6%).  In obese group preterm are 33 
babies (31.7%), baby of GDM mother are 40 babies (40%) and with 
meconium aspiration, 31 babies (29.8%). 
27. Stillbirth was noted in the obese group (about 2%) and no cases in control 
group. 
 CONCLUSION: 
 With a sedentary life style, more in house working pattern and altered food 
habits, there is an increased tendency for the population to move towards obesity. 
This is more so during pregnancy when most of the women tend to take more rest 
and eat different food stuffs to suit their need and taste. The general affluence also 
contributes to the increased incidence of obesity, particularly in pregnancy. 
 The higher incidence of pregnancy complications in obesity is well borne 
out by many studies and this study also correlates with most of the studies. The 
higher incidence of pregnancy complications like anemia, pre eclampsia and 
gestational diabetes are well known affections of obesity. There is also an increased 
incidence of operative delivery and attendant anesthetic complications. 
 The third stage of labor is also fraught with complications in the obese 
women compared to their non obese sisters. The common third stage complications 
are PPH and retained placenta which could be life threatening. 
 Obese babies, even in the absence of GDM, have a higher requirement of 
NICU admission and perinatal complications. Though this study did not reveal any 
increase in perinatal mortality due to obesity, the higher incidence of NICU 
admission is well revealed. Similarly still birth rates are also marginally higher than 
in the non obese women. 
 Hence it is imperative that the fight against obesity should start at the 
adolescent age itself when both the boys and girls tend to indulge in binge eating 
and in junk food. For those obese mothers, the need for restructuring their caloric 
intake and exercise without harming the pregnancy should be stressed. The need of 
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BMI – Body Mass index 
GDM - Gestational Diabetes Milletus 
PIH – Pregnancy Induced Hypertension 
PPH – Postpartum Haemorrhage 
CPD – Cephalopelvic disproportion 
NICU – Neonatal intensive care unit 
IOM – Institute of  Medicine 
NFHS – National Family Health Survey. 
FASTER – First And Second Trimester Evaluation of    Risk trial 
CT – Computerised Tomography 




Name:                                                         Age: 







H/o present illness 
Menstrual history 
                                 Regular/ irregular 
                                 LMP: 
                                 EDD: 
Marital history 
                                     Married since 
                                   Consanguinity 
  
Obestetric history      
                                  G                       P                          L                         A 
                                   Last child birth 
Previous delivery details  
Personal history                  
                     Veg/ Non-veg     
                    Tobacco/ betal nut chewer 
Past medical history 
               H/o Diabetes, Hypertension, Hypothyriodism, Heart disease, 
Tuberculosis, Bronchial asthma, Epilepsy. 
              H/o any previous surgery or blood transfusion. 
Present pregnancy 
I Trimester 
              Hyperemesis 
               Fever 
               Radiation exposure 
               Medication 
               Pain abdomen/ Bleeding pv 
  
II Trimester 
            Date of quickening 
            Gestational diabetes 
            PIH 
            Pain abdomen / Bleeding pv 
III Trimester 
Gestational diabetes 
       PIH 
        Bleeding pv / pain abdomen / draining pv 
General Examination 
           Anemia 
           Pedal edema 
          Breast  
          Thyroid 
Vitals  
         Pulse rate 
        Blood pressure 
        Respiratory rate 
        Prepregnancy weight  
        Weight at present  
        Height 
Examination of  Cardiovascular System 
Examination of  Respiratory System 
Abdominal Examination 
1. Growth of uterus 
a. Symphysiofundal Height 
b. Abdominal circumference 
2. Weight gain during pregnancy 
a. Increasing 
b. Decreasing 




Gestational age at  labour  
a. Preterm 
b. Term 
c. Post dated 
Associated AN Complication  
a. PIH 
b. Gestational diabetes 
c. Anemia 
Onset of  labour 
a. Induction  
b. AccelerationType of delivery 
a. Labour natural 
b. Caesarean delivery 
c. Instrumental delivery 
Intrapartum Complication  
a. Delay in progress 
b. Incoordinate uterine contraction 
c. Prolonged second stage 
Third stage compliation 
a. PPH 
b. Retained placenta 
Neonatal complication 
a. Macrosomia 
b. NICU  admission 
c. Intra uterine death.  
  












































































































































































1 SURIYA 23 7831 PRIMI 19.34 11.5 inc c  NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
2 SANNA 25 3917 PRIMI 22.33 10.9 inc c NIL MILD NIL T NIL 
EM 
LSCS SP NIL NIL 2.4 NO NIL NO 
3 JANAKI 21 8623 PRIMI 23.43 10.3 inc c NIL MILD NIL T NIL 
EM 
LSCS SP NIL NIL 2.6 NO NIL NO 




LSCS NIL NIL 2.7 NO NIL NO 




LSCS NIL NIL 3.3 NO NIL NO 




LSCS NIL NIL 3.3 NO NIL NO 




LSCS NIL NIL 3.4 NO NIL NO 




LSCS NIL NIL 2.8 NO NIL NO 




LSCS NIL NIL 2.7 NO NIL NO 




LSCS NIL NIL 2.1 NO NIL NO 




LSCS NIL NIL 2.6 NO NIL NO 




LSCS NIL NIL 3 NO NIL NO 




LSCS NIL NIL 3 NO NIL NO 




LSCS NIL NIL 2.9 NO NIL NO 




LSCS NIL NIL 3.2 NO NIL NO 




LSCS NIL NIL 2.9 NO NIL NO 




LSCS NIL NIL 3.2 NO NIL NO 
18 VASANTHI 20 3936 PRIMI 21.31 10.9 inc c NIL MILD NIL PT GI LN NIL NIL NIL 1.3 YES PT NO 
19 DEVI 26 4723 PRIMI 23.44 10.5 inc c NIL NIL NIL PT NIL LN NIL NIL NIL 1.2 YES PT NO 
20 KAVYIPRIYA 20 7632 PRIMI 22.45 11.9 inc c NIL MILD NIL PT NIL LN NIL NIL NIL 2.7 YES PT NO 
21 SOPHIARANI 25 5712 PRIMI 20.33 12.5 inc c NIL NIL NIL PT OA LN NIL NIL NIL 1.5 YES PT NO 
22 JENIFER 26 3582 PRIMI 23.03 12.5 inc c NIL NIL NIL T OA IVD NIL NIL NIL 2.9 NO NIL NO 
23 VASANTHI 25 7037 PRIMI 19.99 10.9 inc c NIL NIL NIL T GI LN NIL NIL NIL 3.1 NO NIL NO 
24 GRACY 26 6967 PRIMI 19.88 10.8 inc c NIL MILD YES T GI LN NIL NIL NIL 2.4 NO NIL NO 
25 DEVI 26 4076 G2P1L1 19.76 10.2 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.6 NO NIL NO 
26 PADMA 28 8456 G2P1L1 21 13 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.7 NO NIL NO 
27 VALLI 27 6601 G2P1L1 21.34 1102 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.5 NO NIL NO 
28 SHIVASANKARI 23 6209 G2P1L1 21.34 12.6 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.7 NO NIL NO 
29 AMMU 23 5431 G2P1L1 23.03 12.1 inc c NIL NIL NIL T GI LN NIL NIL NIL 3.6 NO NIL NO 
30 REVATHI 27 4621 PRIMI 21.33 12.9 inc c NIL NIL NIL T GI LN NIL NIL NIL 2 NO NIL NO 
31 SRIBALA 22 4317 PRIMI 22.32 13 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.7 NO NIL NO 
32 SAKILA 20 3544 PRIMI 21.34 10.8 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.6 NO NIL NO 
33 KRITHIKA 23 8438 PRIMI 23.23 9.9 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.5 NO NIL NO 
34 KUMARI 23 8432 PRIMI 21.21 12.5 inc c NIL NIL NIL T GI LN NIL NIL NIL 3 NO NIL NO 
35 CHITANYA 21 7511 PRIMI 22.45 10.8 inc c NIL MILD NIL T GI LN NIL NIL NIL 3.4 NO NIL NO 
36 SUBHASHINI 21 6319 PRIMI 23.43 12.1 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.5 NO NIL NO 
37 ANITHA  21 6051 PRIMI 21.23 11.5 inc c NIL NIL NIL T GI LN NIL NIL NIL 3 NO NIL NO 
38 DURGADEVI 24 5470 PRIMI 22.45 10.8 inc c NIL MILD NIL T GI LN NIL NIL NIL 2.7 NO NIL NO 
39 ALLI 19 5335 PRIMI 19.33 12.5 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.4 NO NIL NO 
40 DESARANI 20 2747 PRIMI 19 12.4 inc c NIL NIL NIL T GI LN NIL NIL NIL 2.6 NO NIL NO 
41 ANURADHA 26 7108 PRIMI 19.22 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
42 RASATHI 29 7231 PRIMI 19.88 13 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
43 PUGALARASI 21 7217 PRIMI 20.23 12.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.7 NO NIL NO 
44 SATHYA 25 7225 PRIMI 22.43 12.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
45 PINKY 18 7137 PRIMI 24.54 11.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
46 MUTHUKALAI 22 6759 PRIMI 20.33 11.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3 NO NIL NO 
47 KALAISELVI 34 4899 G2P1L1 23.43 12.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
48 VIJAYALAKSHMI 24 4761 G2P1L1 21.33 10.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
49 GRACE SHAKILA 24 4707 G2P1L1 23 10.2 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3 NO NIL NO 
50 REVATHY BAI 27 4654 G2P1L1 21.34 11.1 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3 NO NIL NO 
51 MADHINI 23 4599 G2P1L1 20.33 9.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.8 NO NIL NO 
52 EPSY BEULA 24 4570 G2P1L1 21.31 10.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.8 NO NIL NO 
53 LATHA 26 4329 G2P1L1 19.51 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.2 NO NIL NO 
54 PARVEEN BANU 25 4066 G2P1L1 20.01 12.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
55 
MALLIGA 
SULTANA 25 4264 G2P1L1 21.33 12.5 inc c NIL NIL YES T NIL LN NIL NIL NIL 3.3 NO NIL NO 
56 KARTHIGA 24 4129 G2P1L1 24.2 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.2 NO NIL NO 
57 RAGAVENI 21 4137 G2P1L1 20.66 11.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
58 SARANYA 21 4041 G2P1L1 22.34 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.3 NO NIL NO 
59 BARATHI 27 4033 G2P1L1 23.66 11.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
60 VELANKANNI 22 8512 G2P1L1 20.55 10.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
61 MAHALAKSHMI 29 3764 G2P1L1 21.34 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.7 NO NIL NO 
62 KAVITHA 27 3645 G2P1L1 20.45 12.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.8 NO NIL NO 
63 VISALATCHI 29 8174 G2P1L1 23.32 10.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
64 MALINI 23 7992 G2P1L1 21.33 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.8 NO NIL NO 
65 LAVANYA 22 3692 G2P1L1 21.22 10.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
66 SUGANYA 22 7981 G2P1L1 20.45 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
67 LALITHA 33 7800 G2P1L1 19.88 12.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3 NO NIL NO 
68 GOMATHY 25 7674 G2P1L1 21.21 12.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.3 NO NIL NO 
69 SARADHADEVI 32 7584 G2P1L1 22.33 11.9 inc c NIL MILD NIL T NIL LN NIL NIL NIL 2.6 NO NIL NO 
70 SHANTHI 30 7202 G2P1L1 21.34 10.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.3 NO NIL NO 
71 CHITRA 20 7624 G2P1L1 20.33 11.2 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
72 VETTRISELVI 29 7581 G2P1L1 21.23 12.1 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
73 JEEVA 22 7098 G2P1L1 20.33 10.2 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
74 PENCILLAMMA 29 7364 G2P1L1 21.22 10.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
75 KASALIFATHIIMA 26 7242 G2P1L1 18.99 10.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.3 NO NIL NO 
76 JEYA 25 7266 G2P1L1 19.45 11.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
77 KAJABEE 25 7291 G2P1L1 19.34 11.2 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.4 NO NIL NO 
78 TAMILSELVI 21 6251 G2P1L1 21.21 11.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.3 NO NIL NO 
79 THIRUVENI 20 7070 G2P1L1 23.43 12.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
80 NAGARANI 21 7201 G2P1L1 23.33 12.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
81 AMUDHA 24 7083 G2P1L1 23 11.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.3 NO NIL NO 
82 NAMITHA 30 7103 G2P1L1 22.22 12.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
83 SHERIN 28 6677 G2P1L1 23.44 11.1 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.2 NO NIL NO 
84 SUNITHA 22 7068 G2P1L1 21.34 11.1 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
85 INDHU 24 6902 G2P1L1 22.43 13 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
86 NIRMALA 29 6711 G2P1L1 21.34 10.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
87 DIVYA 22 6649 G2P1L1 22.33 12.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3 NO NIL NO 
88 MEGALA 25 6581 G2P1L1 21.23 12.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
89 DHAVAMATHI 25 6766 G2P1L1 22.45 12.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
90 PARAMESHWARI 25 6667 G2P1L1 21.33 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
91 RENUKA 23 6142 G2P1L1 20.45 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
92 MEERA 25 6071 G2P1L1 19.34 11.1 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
93 SHABANABEGAM 26 5893 G2P1L1 21.34 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
94 VALLIAMMA 26 5822 G2P1L1 21.22 12.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
95 SUJATHA 32 5584 G2P1L1 22.43 12.3 inc c NIL MILD NIL T NIL LN NIL NIL NIL 2.7 NO NIL NO 
96 KAMALADEVI 24 5524 G2P1L1 22.33 11.1 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.8 NO NIL NO 
97 VANITHA PRIYA 20 4897 PRIMI 21.21 12.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
98 SHARMILA 24 4871 PRIMI 22.43 13 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.1 NO NIL NO 
99 DHANALAKSHMI 26 4575 PRIMI 22.33 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
100 VANITHA 27 4721 PRIMI 22.22 12.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.2 NO NIL NO 
101 JEYALAKSHMI 26 4889 PRIMI 19.99 10.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.7 NO NIL NO 
102 REVATHY 25 4588 PRIMI 19.33 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.4 NO NIL NO 
103 SALMA 20 4249 PRIMI 20.2 10.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
104 NIRMALADEVI 22 4229 PRIMI 21.22 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.8 NO NIL NO 
105 SARASU 22 4118 PRIMI 22.22 11.1 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2 NO NIL NO 
106 MAHESWARI 21 4165 PRIMI 23.34 10.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.8 NO NIL NO 
107 PRIYADARSHINI 22 4096 PRIMI 21.04 9.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.7 NO NIL NO 
108 DIVYA 19 4044 PRIMI 21.22 10.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2 NO NIL NO 
109 ZUBAITHA  18 3797 PRIMI 21.23 11.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
110 PUSPHALATHA 26 3767 PRIMI 21.44 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3 NO NIL NO 
111 ANJALAI 26 8234 PRIMI 23.22 11.5 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3 NO NIL NO 
112 MARY 22 8042 PRIMI 20.33 9.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
113 KOKILA 24 8027 PRIMI 22.66 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.2 NO NIL NO 
114 JESSY 23 7959 PRIMI 19.04 13 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.6 NO NIL NO 
115 THILAGAVATHY 23 7853 PRIMI 21.22 12.1 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
116 SRUTHI 21 7882 PRIMI 18.99 10.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
117 SWEETHA 19 7727 PRIMI 22.32 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3.3 NO NIL NO 
118 ARULMARY 19 7683 PRIMI 21.23 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
119 REVATHY 21 6888 PRIMI 22.32 10.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
120 SNEKA 21 7374 PRIMI 21.34 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.3 NO NIL NO 
121 VIJAYA 24 7524 PRIMI 21.33 12.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
122 ANJU 20 4834 PRIMI 22.33 10.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 3 NO NIL NO 
123 POWNU 27 6078 PRIMI 19.45 12.3 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
124 SARIDHA 20 5858 PRIMI 21.44 10.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.4 NO NIL NO 
125 SRIBARATHI 22 3615 PRIMI 19.04 12.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
126 GNANESHWARI 20 5730 PRIMI 19.45 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.8 NO NIL NO 
127 MANIBARATHI 20 5147 PRIMI 24.54 9.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
128 NAGOMI 22 5486 PRIMI 22.33 10.6 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
129 DILSATH 20 5322 PRIMI 21.33 10.4 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.6 NO NIL NO 
130 SWEETY 27 5321 PRIMI 23 10.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.5 NO NIL NO 
131 MALAR 23 5437 PRIMI 22.22 11.8 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
132 PACHAIYAMMAL 20 5444 PRIMI 23.44 11.9 inc c NIL NIL NIL T NIL LN NIL NIL NIL 2.9 NO NIL NO 
133 SARANYA 23 7499 PRIMI 21.44 10.9 inc c NIL MILD NIL T OA LN NIL NIL NIL 3.4 NO NIL NO 
134 DIVYA BARATHI 22 7400 PRIMI 21.34 9.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
135 NAHOORMEERA 29 7134 PRIMI 22.33 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
136 VASANTHI 21 3662 PRIMI 19.34 10.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
137 USHA 27 7035 PRIMI 21.33 9.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
138 NALINI 20 6926 PRIMI 19.33 10.4 inc c NIL NIL YES T OA LN NIL NIL NIL 3.1 NO NIL NO 
139 SUMITHRA 23 6965 PRIMI 21.21 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
140 DHANALAKSHMI 19 6907 PRIMI 23.43 11.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
141 RAMYA 23 6723 PRIMI 22.45 10.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 2 NO NIL NO 
142 RESHMA BEGAM 19 6607 PRIMI 20.33 9.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
143 ELAKKIYA 23 6613 PRIMI 22.66 9.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.5 NO NIL NO 
144 BAVYA 19 3655 PRIMI 21.21 11.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
145 MAYA 22 4988 G2P1L1 20.23 12.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
146 ASEENA 21 4653 G2P1L1 22.33 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
147 ANANDHI 26 4195 G2P1L1 24.54 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
148 JEEVA 23 4450 G2P1L1 22.45 12.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
149 SURYA 22 4441 G2P1L1 21.34 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
150 THAMARISELVI 21 3571 G2P1L1 23.44 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
151 KAVYA 23 3889 G2P1L1 21.21 11.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
152 JEYANTHI 26 4273 G2P1L1 19.5 10.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.5 NO NIL NO 
153 GEETHA 28 4125 G2P1L1 20.33 10.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.5 NO NIL NO 
154 GOVINDAMMAL 26 3732 G2P1L1 23.99 12.1 inc c NIL NIL YES T OA LN NIL NIL NIL 2.7 NO NIL NO 
155 SHAKILA 27 3979 G2P1L1 21.89 10.4 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
156 MALLIGA 28 3911 G2P1L1 22.44 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
157 BANUPRIYA 22 3926 G2P1L1 20.2 10.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
158 SAILAJA 23 1140 G2P1L1 21.33 11.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
159 RUPA 28 8956 G2P1L1 21.56 12.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.5 NO NIL NO 
160 PRASANNA 27 8788 G2P1L1 20.8 10.4 inc c NIL NIL NIL T OA LN NIL NIL NIL 2 NO NIL NO 
161 LEELAVATHY 28 8721 G2P1L1 23.89 10.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.5 NO NIL NO 
162 ASHA 28 8214 G2P1L1 19.3 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2 NO NIL NO 
163 SAVITHRI 29 8432 G3P1LIAI 19.8 11.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
164 SASIKALA 29 8523 G3P1LIAI 23.23 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
165 SARALA 28 8348 G2P1L1 20 10.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
166 RANI  26 8622 G2P1L1 22.21 10.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 4.1 NO NIL NO 
167 LAKSHMI 26 4002 G3P1LIAI 21.23 12.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
168 NATHIYA 200 7576 G3P1LIAI 21.44 10.4 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
169 SUNITHA 21 7932 G3P1LIAI 20.33 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
170 SANDHIYA 18 7869 G3P1LIAI 19.45 12.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
171 LAKSMI 23 7579 G3P1LIAI 20.23 12.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
172 SELVI 23 7327 G3P1LIAI 19.04 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
173 RAJALAKSHMI 26 7224 G3P1LIAI 22.33 12.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.3 NO NIL NO 
174 DEEPA 23 7088 G2P1L1 21.33 10.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
175 SANGEETHA 25 7110 G3P1LIAI 23.03 10.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.4 NO NIL NO 
176 RADHIKA 27 7033 G2P1L1 20.33 10.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.3 NO NIL NO 
177 SARANYA 26 6961 G2P1L1 19.34 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
178 TAMILSELVI 21 3545 G3P1LIAI 19.33 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
179 FARITHA 28 6709 G3P1LIAI 22.32 11.5 inc c NIL MILD YES T OA LN NIL NIL NIL 2.8 NO NIL NO 
180 SYEDALIFATHIMA 30 6619 G2P1L1 21.33 9.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
181 SURYAPRIYA 24 6567 G2P1L1 21.44 10.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 3 NO NIL NO 
182 ANANTHY 28 6583 G3P1LIAI 20.45 12.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
183 FATHIMA 23 6548 G3P1LIAI 21.22 9.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
184 ROSE 27 6549 G3P1LIAI 19.04 10.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
185 SUGANYA 22 6450 G3P1LIAI 19.34 11.1 inc c NIL MILD NIL T OA LN NIL NIL NIL 2.5 NO NIL NO 
186 DIVYA 24 6303 G3P1LIAI 22.43 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.1 NO NIL NO 
187 MEENACTHI 23 6342 G3P1LIAI 24.54 11.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.5 NO NIL NO 
188 BANU 26 6262 G4P1LIA3 20.2 12.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
189 SUDHA 24 6192 G4P1LIA3 19.51 10.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
190 JAYASHREE 21 6163 G2P1L1 20.33 12.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
191 REKHA 24 6154 G3P1LIAI 21.44 9.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
192 UMAYAL 22 6126 G3P1LIAI 20.33 10.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.4 NO NIL NO 
193 NIRMALA 22 6117 G2P1L1 21.22 10.02 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.3 NO NIL NO 
194 SARIDHA 23 6091 G2P1L1 18.99 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
195 SHOBANA 27 6030 G3P1LIAI 20.23 10.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3 NO NIL NO 
196 SRIDEVI 25 6015 G3P1LIAI 22.33 10.6 inc c NIL MILD NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
197 LATHA 28 6002 G3P1LIAI 21.23 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
198 KANIMOZHI 21 5940 G3P1LIAI 20.33 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
199 MONISHA 24 5930 G3P1LIAI 21.33 11.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
200 LAKSHMI 25 3348 G3P1LIAI 24.54 12.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.6 NO NIL NO 
201 ANJALIDEVI 20 5786 G4P1LIA3 18.99 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
202 SATHYABAMA 24 5718 G4P1LIA3 19.22 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
203 DEEPIKA 21 5599 G4P1LIA3 21.21 11.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.7 NO NIL NO 
204 MALARVIZHI 24 5570 G4P1LIA3 23.43 10.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
205 SUMATHY 32 5280 G4P1LIA3 23.33 10.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
206 MARY 23 5449 G4P1LIA3 20.33 13 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
207 ARCHANA 25 5300 G4P1LIA3 19.34 12.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
208 NANDHINI 20 5184 PRIMI 19.88 11.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
209 MALARVIZHI 21 3601 PRIMI 23 10.02 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
210 KEERTHI 24 4693 PRIMI 23.03 12.4 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.9 NO NIL NO 
211 NITYA 26 4461 PRIMI 22.33 11.2 inc c NIL NIL YES T OA LN NIL NIL NIL 2.8 NO NIL NO 
212 NEHA 23 4453 PRIMI 21.23 10.4 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
213 MAHESWARI 24 4342 PRIMI 22.22 10.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
214 JEYALAKSHMI 23 4246 PRIMI 22.34 12.4 inc c NIL MILD NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
215 ZEENATH 29 4010 PRIMI 21.21 11.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
216 SHARADHA 23 3991 PRIMI 20.33 13 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
217 PRIYA 22 3067 PRIMI 20.33 12.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
218 JANANI 19 3772 PRIMI 21.33 12.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.3 NO NIL NO 
219 TAMILARASI 24 3505 PRIMI 20.33 10.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
220 KRISHNAVENI 25 8988 PRIMI 22.8 10.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
221 SUGUNA 22 8733 PRIMI 23.01 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 3 NO NIL NO 
222 DARANI 25 8654 PRIMI 23.32 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
223 MARIAMMAL 24 8532 PRIMI 22.11 12.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
224 SATYAVANI 21 8666 PRIMI 22.22 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
225 VASUKI 25 8324 PRIMI 23.33 10.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
226 VIJAYA 20 3894 PRIMI 21.34 10.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
227 SIDDIQFATHIMA 18 8010 PRIMI 21.34 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.5 NO NIL NO 
228 RAMYA 19 7643 PRIMI 21.22 11.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
229 GOMATHY 21 7357 PRIMI 18.99 10.4 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.4 NO NIL NO 
230 NITYA 28 7767 PRIMI 19.04 10.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
231 YUVARANI 22 3481 PRIMI 19.04 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
232 SABOORNISHA 23 7510 PRIMI 22.66 11.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
233 DURVESHNISH 21 6550 PRIMI 20.33 10.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
234 VIMALA 20 6534 PRIMI 18.99 10.4 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
235 GUNAVATHY 30 6444 PRIMI 22.44 12.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
236 NAGAMMAL 18 6492 PRIMI 19.88 10.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.4 NO NIL NO 
237 BHARATHI 21 6487 PRIMI 20.23 10.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.3 NO NIL NO 
238 MADUMATHI 27 3252 PRIMI 23.43 10.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.3 NO NIL NO 
239 SAKILA 21 6344 PRIMI 23.33 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 3 NO NIL NO 
240 AMUDHA 28 6324 PRIMI 21.33 13 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
241 BAVANI 21 3652 PRIMI 22.43 13 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.2 NO NIL NO 
242 DHIVYA 19 6196 PRIMI 22.32 11.8 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
243 KALPANA 22 6165 PRIMI 21.34 11.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.6 NO NIL NO 
244 SHEELADEVI 21 6150 PRIMI 21.34 11.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
245 ALMAS 20 6046 PRIMI 19.04 11.1 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.1 NO NIL NO 
246 HASIRABANU 24 5976 PRIMI 19.22 10.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 3 NO NIL NO 
247 SUBATHRADEVI 23 6061 PRIMI 19.88 10.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.3 NO NIL NO 
248 BHUVANESHWARI 19 6033 PRIMI 21.21 9.9 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.7 NO NIL NO 
249 RAJESWARI 20 6012 PRIMI 22.32 10.4 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
250 VIDHYA 21 5864 PRIMI 22.66 13 inc c NIL NIL NIL T OA LN NIL NIL NIL 3 NO NIL NO 
251 MANJU 22 5816 PRIMI 21.34 11.5 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.8 NO NIL NO 
252 IYYAMMAL 27 5878 PRIMI 20.45 12.6 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
253 MAHALAKSHMI 20 5716 PRIMI 19.34 10.3 inc c NIL NIL NIL T OA LN NIL NIL NIL 3.1 NO NIL NO 
254 KANIMOZHI 24 5450 PRIMI 21.34 11.2 inc c NIL NIL NIL T OA LN NIL NIL NIL 2.9 NO NIL NO 
255 SARASWATHI 22 5413 PRIMI 19 11.5 inc c NIL MILD NIL T OA LN NIL NIL NIL 2.3 NO NIL NO 
256 SUSEELA 24 8701 PRIMI 23.54 12.3 inc b NIL NIL NIL T NIL 
EM 
LSCS BREECH NIL NIL 2.4 NO NIL NO 
257 SATYA 20 3915 PRIMI 22.45 11.1 inc b NIL NIL NIL T NIL 
EM 
LSCS BREECH NIL NIL 2.7 NO NIL NO 
258 RADHA 22 5646 PRIMI 20.23 12 inc b NIL NIL NIL T NIL 
EM 
LSCS BREECH NIL NIL 2.5 NO NIL NO 
259 JOHARA 23 4792 G4P1LIA3 23.33 10.2 inc b NIL NIL NIL T NIL 
EM 
LSCS BREECH NIL NIL 2.5 YES MAS NO 
260 DEVI 27 3688 PRIMI 22.66 12.4 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 2.4 NO NIL NO 
261 MANJULA 23 8945 PRIMI 22.56 11.1 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 2.3 NO NIL NO 
262 PARVATHY 18 4016 PRIMI 22 11.8 inc c NIL NIL NIL T GI 
EM 
LSCS FD NIL NIL 3.6 YES MAS NO 
263 SIVAGAMI 23 8311 PRIMI 20.44 10.02 inc c NIL MILD NIL T GI 
EM 
LSCS FD NIL NIL 3.2 YES MAS NO 
264 KOWSALYA 23 8756 PRIMI 22.66 12.3 inc c NIL MILD NIL T GI 
EM 
LSCS FD NIL NIL 2.5 YES MAS NO 
265 SHAMEEMA 24 7850 PRIMI 19.22 11.1 inc c NIL MILD NIL T GI 
EM 
LSCS FD NIL NIL 3.3 YES MAS NO 
266 MEENA 28 5477 PRIMI 22.33 10.4 inc c NIL MILD NIL T GI 
EM 
LSCS FD NIL NIL 2.5 YES MAS NO 
267 JENNI 24 4424 PRIMI 20.33 11.8 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 2.7 YES MAS NO 
268 SARITHA 25 4169 PRIMI 19.23 11.9 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 3.4 YES MAS NO 
269 DOWLATH BANU 23 3821 PRIMI 22.45 10.6 inc c NIL MILD NIL T NIL 
EM 
LSCS FD NIL NIL 3.2 YES MAS NO 
270 KANNIKA 21 3807 PRIMI 21.34 10.3 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 2.7 YES MAS NO 
271 UMAVATHI 21 8411 PRIMI 21.65 10.2 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 2.7 YES MAS NO 
272 MUTHULAKSHMI 21 7360 PRIMI 20.45 10.9 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 3.2 YES MAS NO 
273 MAHESWARI 22 3667 PRIMI 19.45 9.9 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 3.1 YES MAS NO 
274 MAHA 23 6885 PRIMI 20.23 11.9 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 2.9 YES MAS NO 
275 RAJESWARI 23 3633 PRIMI 19.88 10.6 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 2.8 YES MAS NO 
276 VAKITA 23 3500 PRIMI 23.33 12.1 inc c NIL NIL NIL T NIL 
EM 
LSCS FD NIL NIL 3 YES MAS NO 
277 VALLI 24 5424 PRIMI 21.33 10.8 inc c NIL NIL NIL T OA 
EM 
LSCS FD NIL NIL 2.8 YES MAS NO 
278 GAYATHIRI 20 6666 PRIMI 21.34 12.4 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3.1 NO NIL NO 
279 KANIMOZHI 23 3575 PRIMI 20.23 11.8 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 2.7 NO NIL NO 
280 NABEESA BEGAM 28 4322 G4P1LIA3 21.34 11.9 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3.2 NO NIL NO 
281 RANJANI 20 4058 PRIMI 23.33 11.9 inc c NIL NIL YES T NIL 
EM 
LSCS CPD NIL NIL 3.3 NO NIL NO 
282 ANITHA  22 4170 PRIMI 23.32 12.3 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 2.9 NO NIL NO 
283 PUSPHA 26 2953 PRIMI 21.34 12.5 inc c NIL MILD NIL T NIL 
EM 
LSCS CPD NIL NIL 2.8 NO NIL NO 
284 UMA 20 8333 PRIMI 22.32 11.9 inc c NIL MILD NIL T NIL 
EM 
LSCS CPD NIL NIL 2.5 NO NIL NO 
285 CHANDRA 24 8431 PRIMI 22.44 11.8 inc c NIL MILD NIL T NIL 
EM 
LSCS CPD NIL NIL 3.2 NO NIL NO 
286 RADHA 22 8754 PRIMI 22.33 12.4 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3.4 NO NIL NO 
287 YAMINI 23 6288 PRIMI 21.31 11.8 inc c NIL MILD NIL T NIL 
EM 
LSCS CPD NIL NIL 3.2 NO NIL NO 
288 LAVANYA 19 6143 PRIMI 22.45 12.5 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3.4 NO NIL NO 
289 NAGARATHINAM 20 5994 PRIMI 22.66 12.4 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3.2 NO NIL NO 
290 SENTHAMARAI 22 5656 PRIMI 19.88 10.02 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3.3 NO NIL NO 
291 SHOBANA 24 3577 PRIMI 22.22 12.1 inc c NIL NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 2.9 NO NIL NO 




LIE NIL NIL 2.4 YES GDM NO 
293 KANNIAMMAL 23 4008 G4P1LIA3 22.45 11.8 inc c MEALPLAN NIL NIL T NIL LN NIL NIL NIL 2.5 YES GDM NO 
294 ARPUTHAM 29 5330 G2P1L1 19.99 10.3 inc c MEALPLAN NIL NIL T NIL LN NIL NIL NIL 2.7 YES GDM NO 
295 DHANALAKSHMI 27 7922 PRIMI 19.22 13 inc c MEALPLAN NIL NIL T OA IVD NIL NIL NIL 2.6 YES GDM NO 
296 NADHIYA 24 6329 PRIMI 22.33 11.3 inc b MEALPLAN NIL NIL T NIL 
EM 
LSCS BREECH NIL NIL 2.4 YES GDM NO 
297 KOTTESWARI 20 6563 PRIMI 21.34 11.2 inc c MEALPLAN NIL NIL T NIL 
EM 
LSCS BREECH NIL NIL 2.5 YES GDM NO 
298 ALAMELU 23 8432 PRIMI 22.22 11.9 inc c MEALPLAN NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3.2 YES GDM NO 
299 BRINDHA 21 3614 PRIMI 20.33 11.2 inc c MEALPLAN NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3 YES GDM NO 
300 KANNIAMMAL 19 7438 PRIMI 20.33 12.5 inc c MEALPLAN NIL NIL T NIL 
EM 
LSCS CPD NIL NIL 3.1 YES GDM NO 
 
  






















































































































































































1 Nandhini 23 19749 primi 34.22 8 inc c NO severe  NO PT nil 
EM 





2 Bavani 29 10125 primi 31.2 8.8 inc c 
INSU
LIN nil NO T nil 
EL 





































7 Reshma 20 12843 primi 31.18 9 inc c no severe  NO PT nil 
EM 












9 Estherclara 21 12186 primi 30.35 8.7 inc c no mild NO T OI 
EM 





10 Thamarai selvi 27 11568 primi 34.96 8.9 inc c no nil NO PT nil 
EM 

























































































vimala 26 12475 G3P1L1A1 33.29 6.6 inc c NO severe  NO T nil 
EM 























26 Prema 24 14589 primi 36.31 7.8 inc c no mild NO T OI 
EM 
























































32 Satya 22 13253 G2P1L0 32.29 8.7 inc c 
INSU











33 Yasmin  23 6233 primi 32.45 8.9 inc c 
MEA
LPLA




























































39 Shameem 29 3554 G2P1L1 36.9 8.6 inc b 
INSU











40 Chitra 23 4549 primi 33.32 8.8 inc c no mild NO T nil 
EM 

















































































49 Vigneshwari 18 7419 primi 37.83 7.8 inc c no mild NO T GI 
EM 















52 Gayathri 27 7847 primi 33.29 6.8 inc c no mild NO T OA 
EM 


















ine 30 5957 G2P1L1 32.81 8 inc t 
INSU
LIN nil NO T nil 
ELR 







55 Bakiyalakshmi 23 7827 primi 32.04 8.2 inc c no mild NO T OA 
EM 





56 Femina 27 7925 primi 30.66 7.3 inc c no mild NO T OI 
EM 


















58 Shahin begam 24 8023 G2P1L1 37.5 7 inc c 
INSU






































begam 31 8197 primi 35.33 7.4 inc c no severe  NO T nil 
EM 
















64 Nisha 19 7365 primi 34.19 6.5 inc c no severe  NO PT nil 
EM 







sulthana 23 9427 primi 31.25 8 inc c no severe  NO T nil 
EM 





66 Shameena 19 9673 primi 30.81 6.6 inc c 
INSU
LIN nil NO T nil 
EM 







67 Kavitha 24 10820 primi 30.75 7 inc c 
MEA
L 
PLA nil NO T nil 
EM 












































72 Sasikala 26 7763 primi 32 6.8 inc c no mild NO PT nil 
EM 






























76 Saranya 20 8916 primi 30.09 7.8 inc c no nil NO T nil 
EM 
































80 Indira 28 12317 G3P2L2 35.49 7.8 inc c 
INSU





























83 Praveena 23 20464 G3p1l1A2 33.73 6.8 inc c 
INSU



































































90 Thuya mary 22 3927 primi 32.43 7.2 inc c no mild NO T OI 
EM 







91 Indhumathi 20 3935 primi 30.13 7.4 inc c no severe  NO T GI 
EM 





92 Dilsath begam 18 3878 primi 31.25 6.8 inc c no mild NO T GI 
EM 














94 Rajani 21 4242 G3P1L1A1 30.85 8 inc c no severe  NO PT nil 
EM 






























98 Amalya 27 5278 G2P1L1 30.31 7.4 inc c 
INSU
































102 Amirtha 24 15893 primi 32.02 7.3 inc c no mild NO PT nil 
EM 
































106 Vanitha 23 16072 primi 30.06 7.7 inc c no nil NO T nil 
EM 




























110 Usha 30 16026 G3P2L2 35.39 7.5 inc c 
INSU

































113 Jayavani 25 34648 G3p1l1A3 33.74 7.4 inc c 
INSU

































































120 Saraswathy 24 12432 primi 32.44 7.4 inc c no mild NO T OI 
EM 












122 Vasantha 28 14563 primi 33.22 6.5 inc c no mild NO T OA 
EM 
















124 Vasanthi 30 14356 G2P1L1 32.83 7.3 inc t 
INSU
LIN nil NO T nil 
ELR 







125 Sargunam 23 14568 primi 32.06 7.6 inc c no mild NO T OA 
EM 





126 Gandhimathi 26 13456 primi 30.65 7.8 inc c no mild NO T GI 
EM 
















128 Thara 25 15234 G2P1L1 37.52 7.7 inc c 
INSU
































132 Jeyabharathi 31 9002 primi 35.34 7.2 inc c no severe  NO T nil 
EM 














134 Leela 20 9134 primi 34.09 6.8 inc c no severe  NO PT nil 
EM 





135 Amsaveni 22 9255 primi 31.35 6.5 inc c no severe  NO T nil 
EM 





136 Kaveri 19 9348 primi 30.83 8 inc c 
INSU
LIN nil NO T nil 
EM 









N nil NO T nil 
EM 
































141 Preethi 21 9534 primi 30.23 6.8 inc c no severe  NO T nil 
EM 





142 Brindha 19 9678 primi 31.23 6.5 inc c no mild NO T GI 
EM 














144 vasantha 23 9456 G3P1L1A1 30.65 7.3 inc c no severe  NO PT nil 
EM 





145 Manonmani 25 16079 primi 32.42 7.6 inc c no mild NO T nil 
EM 





















148 Parimala 29 16368 G2P1L1 30.33 7.7 inc c 
INSU






























152 Kantha 31 12859 G2P1L0 32.28 7.4 inc c 
INSU









































































159 Kasiammal 27 13808 G2P1L1 36.92 7.4 inc b 
INSU











160 Thilaga 28 13236 primi 33.33 6.8 inc c no mild NO T nil 
EM 















































































169 Sara 31 14727 primi 37.83 7.5 inc c no mild NO T nil 
EM 












171 Sharmila 21 14317 primi 34.24 7.2 inc c no mild NO PT nil 
EM 





172 Hemalatha 30 15770 primi 31.23 7.4 inc c 
INSU
LIN nil NO T nil 
EL 
















174 Seetha 28 14395 G2P1L1 32.84 6.5 inc c no  mild YES T GI LN nil nil nil 3.8 n NO N
o O 














177 Nirosha 21 15407 primi 31.16 7.8 inc c no severe  NO PT nil 
EM 










179 Sugumari 22 15700 primi 30.34 7.4 inc c no mild NO T OI 
EM 





180 Unnamalai 28 15789 primi 34.94 6.8 inc c no nil NO PT nil 
EM 























183 Karpagam 24 15724 primi 36.78 7.3 inc c no mild NO T nil 
EM 
































































193 Madhumidha 27 18841 G3P1L1A1 33.28 6.5 inc c NO severe  NO T nil 
EM 























196 Lalitha 25 19450 primi 36.32 7.7 inc c no mild NO T OI 
EM 











































201 Prema 22 2320 primi 30.111 7.8 inc c no severe  NO T GI 
EM 





202 Raji 20 2323 primi 31.22 7.2 inc c no mild NO T GI 
EM 












204 Surekha 25 2314 G3P1L1A1 30.83 6.8 inc c no severe  NO PT nil 
EM 





205 jayashree 24 2312 primi 32.41 6.5 inc c no mild NO T nil 
EM 























208 Adilakshmi 29 2765 G2P1L1 30.29 7.6 inc c 
INSU









































213 Pugalmathi 25 9932 G3p1l1A4 33.73 6.6 inc c 
INSU































































220 Surya 24 10306 primi 32.45 6.5 inc c no mild NO T OI 
EM 
















222 Nithya 29 10471 primi 35.33 9 inc c no severe  NO T nil 
EM 














224 Yamuna 21 10527 primi 34.19 9.8 inc c no severe  NO PT nil 
EM 





225 Rani 25 10645 primi 31.25 9.3 inc c no severe  NO T nil 
EM 





226 Poonkuzhali 21 10590 primi 30.81 9.7 inc c 
INSU
LIN nil NO T nil 
EM 











N nil NO T nil 
EM 









































232 Bargavi 28 10932 primi 32 7.2 inc c no mild NO PT nil 
EM 




























236 kalaivani 22 11283 primi 30.09 8 inc c no nil NO T nil 
EM 






























240 Sabitha 30 11655 G3P2L2 35.49 8.7 inc c 
INSU
















242 Girija 29 11865 primi 33.29 7.8 inc c no mild NO T OA 
EM 
















244 Sabeena 28 11623 G2P1L1 32.81 7.4 inc t 
INSU
LIN nil NO T nil 
ELR 







245 Prarthana 25 11403 primi 32.04 6.8 inc c no mild NO T nil 
EM 





246 Aarthi 29 12008 primi 30.66 6.5 inc c no mild NO T nil 
EM 
















248 Narmadha 26 12233 G2P1L1 37.5 7.3 inc c 
INSU

























251 Pothumponnu 24 12456 primi 34.22 6.9 inc c no severe  NO PT nil 
EM 





252 Mangalam 28 12445 primi 31.2 7.7 inc b 
INSU







































257 sakthi 22 13687 primi 31.18 6.8 inc c no severe  NO PT nil 
EM 










259 Seethalakshmi 23 13998 primi 30.35 8 inc c no mild NO T OI 
EM 







260 Renuka 29 14234 primi 34.96 7.3 inc c no nil NO PT nil 
EM 



















263 Mythili 28 14123 G3P1L1A1 33.29 6.9 inc c NO severe  NO T nil 
EM 























266 Chinnathai 26 14502 primi 36.31 6.9 inc c no mild NO T OI 
EM 









































271 Jeyarani 26 14723 primi 33.32 8.8 inc c no mild NO T nil 
EM 













































































280 Jannet 22 15302 primi 37.83 8 inc c no mild NO T nil 
EM 





























N mild NO T nil 
EM 







   






















































292 Kokila 25 15123 G2P1L0 32.29 6.6 inc c 
INSU




















































296 Jayasheeli 33 6384 G2A1 32.03 7.2 inc c NO nil NO T OI 
EM 







si 26 6817 primi 32 7.4 inc c no severe  NO T nil 
EM 

















300 Vaijeyanthi 39 6989 primi 31.33 8 inc c no mild NO T nil 
EL 





KEY TO MASTER CHART 
 
inc – Increasing 
c – Cephalic 
b – Breech 
tran – transverse lie 
T –Term 
PT – Preterm 
GI – PGE2 gel induction 
OI – Oxytocin induction 
OA – Oxytocin acceleration 
LN – Labour natural 
IVD – Intrumental vaginal delivery 
EL LSCS – Elective LSCS 
ELR LSCS – Elective repeat LSCS 
EM LSCS – Emergency LSCS 
EMR LSCS – Emergency repeat LSCS 
SP – Severe preeclampsia 
CPD – Cephalopelvic disproportion 
FD – Fetal distress 
FI – Failed induction 
DP- Delay in progress 
RP- Retained placenta 
 
